Clinical Research

The History of Clinical Trials: From Scurvy to mRNA Vaccines

The History of Clinical Trials: From Scurvy to mRNA Vaccines

Every medication currently available began as an experiment. The history of clinical trials spans centuries, from simple comparisons on ships to the most sophisticated large-scale scientific endeavors in history.

The First Controlled Clinical Trial: James Lind, 1747

On a British naval vessel, ship’s surgeon James Lind took 12 sailors with scurvy and systematically assigned pairs to different treatments: cider, dilute sulfuric acid, vinegar, sea water, an herbal remedy, and citrus fruit.

Within six days, the two sailors given oranges and lemons had largely recovered. This simple experiment, arguably the first controlled clinical trial, eventually saved thousands of lives and led to the British Navy’s lemon ration.

The Mid-20th Century: Randomization and Double-Blinding

The modern clinical trial took shape in 1948 with the first truly randomized controlled trial: the MRC streptomycin trial for tuberculosis, led by Austin Bradford Hill. Hill introduced random allocation and statistical analysis, establishing the framework that governs all clinical research today.

The Thalidomide Tragedy and Regulatory Reform

In the early 1960s, thalidomide, prescribed to pregnant women for morning sickness, caused severe limb abnormalities in thousands of children in Europe. In the United States, FDA pharmacologist Frances Kelsey refused to approve thalidomide due to insufficient safety data.

This led directly to the 1962 Kefauver-Harris Amendment, requiring proof of both safety AND efficacy before FDA approval, the standard that governs drug approval to this day.

The HIV/AIDS Era

The AIDS crisis of the 1980s led dying patients to demand faster access to experimental therapies. Patient advocacy organizations fundamentally changed how clinical trials were conducted, leading to accelerated approval pathways, expanded access programs, and greater patient voice in trial design.

mRNA Vaccines and the Modern Era

The COVID-19 vaccines of 2020 reached Phase III completion and emergency use authorization in under a year, possible not because safety was compromised but because unprecedented funding allowed simultaneous development phases and massive enrollment.

Learn about participating in today’s clinical trials at NuLine.

Share:
See If You Qualify Call Now